Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
 Index 
 Full text 
Debates
Thursday, 17 April 2014 - Strasbourg Revised edition

New psychoactive substances (A7-0172/2014 - Jacek Protasiewicz)
MPphoto
 
 

  Claudette Abela Baldacchino (S&D), in writing. - This is a very important dossier. The rising number of new psychoactive substances available in the EUʼs internal market, their growing diversity, both in type and risk level, the speed with which they emerge and the growing number of individuals who consume them, challenge the capacity of public authorities to provide effective responses to protect public health and safety without hampering legitimate trade. New psychoactive substances can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer ‘Youth attitudes on drugsʼ, 5[nbsp ]% of young people in the EU have used such substances at least once in their life, with a peak of 16[nbsp ]% in Ireland, and close to 10[nbsp ]% in Poland, Latvia and the United Kingdom. The consumption of new psychoactive substances can cause harm to the health and safety of individuals and can pose risks and burdens for society as it may lead to violent behaviour and crime. If we truly believe in a Social Europe where everybody matters we need to stress even more the social aspect of society through the ‘respect yourselfʼ notion.

 
Legal notice - Privacy policy